Predictive Biosciences, Inc., a molecular diagnostics company, develops diagnostic products for informed cancer management. It specializes in proteomics, diagnostics, oncology, and tumor biomarkers. The company offers biomarkers and proteomics-based assay technologies. These assays detect urinary biomarkers associated with the physiological changes resulting from cancer development and progression. It also provides Triage Monitoring Assay, which allows physicians to delay and invasive diagnostic procedures; Interval Monitoring Assay that is for surveillance and detection of cancer between follow-ups; and Stratification Assay, which supports a physicianâ€™s decision to manage a patient.
Predictive Biosciences, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Current Team (4)Update
Past Team (5)Update
Funding Rounds (3) - $56.8MUpdate
Board Members and Advisors (7)Update
Healthcare Investment Group
Global venture capital firm helping entrepreneurs build transformational businesses across...
Early stage venture capital firm
Global Venture Capital Firm
128 Spring Street
400 Level, B Annex
Lexington, MA 02421